Nucleic Acid Therapeutics for Neurological Diseases
Neurotherapeutics
.
2019 Apr;16(2):245-247.
doi: 10.1007/s13311-019-00736-1.
Authors
Jonathan K Watts
1
,
Robert H Brown
2
3
,
Anastasia Khvorova
2
Affiliations
1
RNA Therapeutics Institute, UMass Medical School, Worcester, Massachusetts, 01605, USA.
[email protected]
.
2
RNA Therapeutics Institute, UMass Medical School, Worcester, Massachusetts, 01605, USA.
3
Department of Neurology, UMass Medical School, Worcester, Massachusetts, 01605, USA.
PMID:
31037650
PMCID:
PMC6554381
DOI:
10.1007/s13311-019-00736-1
No abstract available
Publication types
Editorial
MeSH terms
Animals
Humans
Nervous System Diseases / drug therapy*
Nucleic Acids / therapeutic use*
Oligonucleotides / therapeutic use*
Substances
Nucleic Acids
Oligonucleotides
Grants and funding
R01 NS111990/NS/NINDS NIH HHS/United States
S10 OD020012/OD/NIH HHS/United States
R01 NS088689/NS/NINDS NIH HHS/United States
R01 NS079836/NS/NINDS NIH HHS/United States
UG3 TR002668/TR/NCATS NIH HHS/United States
UH3 TR000888/TR/NCATS NIH HHS/United States
R01 NS104022/NS/NINDS NIH HHS/United States